Neurocrine Bioscience buy UBS Group AG
Start price
09.10.25
/
50%
€119.80
Target price
09.10.26
€167.52
Performance (%)
-6.55%
Price
11.03.26
€111.95
Summary
This prediction is currently active. With a performance of -6.55%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 09.10.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -0.885% | -0.885% |
| iShares Core DAX® | -2,53 % | -5,19 % |
| iShares Nasdaq 100 | -0,03 % | 1,56 % |
| iShares Nikkei 225® | -4,20 % | -7,55 % |
| iShares S&P 500 | -0,80 % | 0,16 % |
Comments by UBS_Group_AG for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at UBS Group AG from $188.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.20
23.01.26
23.01.26
€151.53
23.01.27
23.01.27
-2.82%
11.03.26
11.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€113.95
09.07.25
09.07.25
€148.44
09.07.26
09.07.26
-1.76%
11.03.26
11.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€134.58
06.05.26
06.05.26
3.51%
11.03.26
11.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€86.72
04.04.25
04.04.25
€123.79
04.04.26
04.04.26
29.09%
11.03.26
11.03.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
08.01.25
08.01.25
€157.20
08.01.26
08.01.26
-14.59%
09.01.26
09.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.45
28.05.24
28.05.24
€177.37
28.05.25
28.05.25
-13.52%
29.05.25
29.05.25